Cancer Nanomedicine

doi:10.3390/books978-3-03943-059-8

Format

Hardback

License and Copyright

Keywords

antibody drug conjugate (ADC); PD-L1; tumor spheroid disruption; immune modulation; doxorubicin; graphene oxide; adsorption; cathepsin D; cathepsin L; anti-metastatic enzyme cancer therapy; nanoparticles; targeted delivery system; siRNA; osteopontin; mammary carcinoma; mesenchymal stem cells (MSCs); TAT peptide; PLGA; paclitaxel; nano-engineered MSCs; orthotopic lung tumor model; intracranial glioma; immunotherapy; CPMV; viral nanoparticles; in situ vaccine; albumin nanoparticles; microbubble; ultrasound; theranostics; hepatocellular carcinoma; VX2 tumor; intra-arterial chemotherapy; lung cancer; nanomedicine; theranostics; clinical status; cancer therapy; breast cancer; siRNA; cell signaling; active targeting; passive targeting; EPR effect; oncogenes; nanoparticles; nanomedicine; nanoparticle; drug delivery; ligand; active targeting; tumor targeting; biodistribution; Mesoporous silica nanoparticle; drug delivery system; target treatment; lanthanide metal; TAT peptide; hyaluronic acid; hyaluronidase; nanoparticles; drug combination; paclitaxel; everolimus; dual-targeting; breast cancer; graphene oxide; magnetic nanoparticles; monoclonal antibodies; tumor targeting; nanostructured lipid carrier; platelet membrane; biomimicry; paclitaxel; plasmonic photothermal therapy; gold nanorods; surgery; bleeding; dogs; cats; breast cancer; nanomedicine; drug delivery; stimuli-responsive; DOX; SN38; CSCs; single-walled carbon nanotubes; chirality separation; NASH; drug-gene delivery; near IR hyperspectral imaging; plasmonics; nanomedicine; theranostics; copper; VEGF; glioblastoma; differentiated neuroblastoma; peptidomimetics; real-time quantitative polymerase chain reaction (qPCR); actin; nanoparticles; combinatorial therapy; anticancer and antibacterial activity; temoporfin; drug-in-cyclodextrin-in-liposome; hybrid nanoparticles; multicellular tumor spheroids; cyclodextrins; photodynamic therapy article; yet reasonably common within the subject discipline; antitumor strategy; biomimetic core–shell nanoparticles; NK cell-derived exosomes; drug delivery system; folate receptor; albumin nanoparticle; microfluidic; cabazitaxel; polydopamine nanoparticles; size; cytotoxicity; iron affinity; doxorubicin; nanomedicine; FA-DABA-SMA; self-assembly; oncogenic proteins; intracellular disruption; folic receptor alpha; active targeting; drug delivery; pancreatic cancer; parvifloron D; nanoparticles; albumin; erlotinib; photodynamic therapy; lipid nanoparticles; drug delivery system; tumor vectorization; verteporfin; ovarian carcinomatosis; spheroids; nanomedicine; nanoparticles; integrin; RGD peptide; active targeting; cancer diagnosis; drug delivery; radiotherapy; hyperthermia therapy; biomimetic; nanocarrier; membrane-wrapped; cancer; targeted delivery; drug delivery; immunotherapy; photothermal therapy; photodynamic therapy; imaging; cancer nanomedicine; EPR effect; tumor microenvironment; nanoparticles; nano–bio interactions; clinical translation; magnetic nanowires; cancer; magnetic hyperthermia; magnetic actuation; magnetic drug targeting; titanate nanotubes; gold nanoparticles; vectorization; nanocarrier; colloidal stability; docetaxel; cytotoxicity; biodistribution; radiotherapy; prostate cancer; nanoparticles; mangiferin; anti-topoisomerase activity; cytotoxicity; extracellular vesicles; exosomes; chemico-physical functionalization; loading; cancer; nanomedicine; translational medicine; nanotechnology: bioengineering; anacardic acid; mitoxantrone; targeted drug delivery; liposomes; melanoma; apoptosis; ascorbic acid; angiogenesis; epithelial-to-mesenchymal transition; hypoxia; immunosuppression; metabolism; nanoparticle; nanotherapeutics; tumour microenvironment; DNA origami; liposome; breast cancer; remote loading; doxorubicin; acute toxicity; organoids; magnetic silica-coated iron oxide nanochains; nanoparticles; photothermal treatment; hyperthermia; cancer; collagen; cellular microenvironment; lymphadenectomy; magnetometer; prostate cancer; sentinel lymph node dissection; SPION; superparamagnetic iron oxide nanoparticles; Vδ2 T cells; zoledronic acid; polymeric nanoconstruct; anti-tumor immunity; colorectal carcinoma; β-cyclodextrin nanosponges; doxorubicin; breast cancer; BALB-neuT mice; EPR effect; brain tumours; glioma; blood brain barrier; drug delivery; nanomedicine; polymeric nanoparticles; PEGylation; dioleoylphosphatidylethanolamine; liposomes; poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer; folate; oxidation-sensitive release; doxorubicin; cellular interaction; in vitro anti-cancer activity; triple negative breast cancer; organotin; mesoporous silica nanoparticles; MDA-MB-231; theranostic nanomaterials; nanobiotechnology; molecular imaging; nanosystems; drug delivery; nanomicelles; ovarian cancer; tumour targeting; chemotherapeutics; riboflavin; vitamin B2; targeted drug delivery; active targeting; theranostics; nanomedicines; molecular imaging; nanoparticle; secondary structure; mixed micelle; pH responsive; drug delivery system; nanomedicine; nanoparticle; targeted therapy; anti-cancer; shear stress; flow; in vitro; cancer nanomedicine; therapeutics; diagnostics; imaging; theranostics; Immunotherapy; tumour microenvironment

Reprint

Download Flyer

Cancer Nanomedicine

Edited by

September 2020

510 pages

ISBN 978-3-03943-058-1 (Hardback)
ISBN 978-3-03943-059-8 (PDF)

https://doi.org/10.3390/books978-3-03943-059-8

Free Download (PDF)

This is a Reprint of the Special Issue Cancer Nanomedicine that was published in

Biology & Life Sciences

Medicine & Pharmacology

Summary

This special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field.

Related Books

September 2020

Cancer Nanomedicine

Related Books

Cancer Nanomedicine

Recent Progress of Nanomedicine and Targeted Drug Delivery for Cancer Treatment

Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies

Nanocolloids for Nanomedicine and Drug Delivery

Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment